TCHAD GRIFFIN: Open Payments
NPI 1306930813 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 77 payments from 16 companies in 2025. Trend: 2023 $1,961 · 2024 $1,489 · 2025 $1,463
Food & beverage: $1,451Education: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $244 |
| Corcept Therapeutics | 13 | $206 |
| Vanda Pharmaceuticals Inc. | 5 | $144 |
| ABBVIE INC. | 8 | $139 |
| GlaxoSmithKline, LLC. | 10 | $138 |
| Novo Nordisk Inc | 6 | $117 |
| Lilly USA, LLC | 6 | $104 |
| PFIZER INC. | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
Products named: Korlym, AIRSUPRA, HETLIOZ, TRELEGY ELLIPTA, ELIQUIS, CAPLYTA, Ozempic, MOUNJARO.
Industry payments across TN — which companies pay providers there.
